Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Common Equity (2016 - 2026)

Varex Imaging (VREX) has disclosed Common Equity for 11 consecutive years, with $490.8 million as the latest value for Q1 2026.

  • On a quarterly basis, Common Equity fell 10.47% to $490.8 million in Q1 2026 year-over-year; TTM through Jan 2026 was $490.8 million, a 10.47% decrease, with the full-year FY2025 number at $486.6 million, down 10.42% from a year prior.
  • Common Equity was $490.8 million for Q1 2026 at Varex Imaging, up from $486.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $590.4 million in Q2 2024 to a low of $486.6 million in Q4 2025.
  • A 5-year average of $543.3 million and a median of $543.2 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: grew 11.05% in 2023, then decreased 10.47% in 2026.
  • Varex Imaging's Common Equity stood at $525.0 million in 2022, then rose by 11.05% to $583.0 million in 2023, then decreased by 6.83% to $543.2 million in 2024, then fell by 10.42% to $486.6 million in 2025, then increased by 0.86% to $490.8 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Common Equity are $490.8 million (Q1 2026), $486.6 million (Q4 2025), and $557.9 million (Q2 2025).